Wilbur A Lam, MD, PhD

Pediatric Hematologist/Oncologist


Primary Specialty



Board Certification
Am Bd Pediatrics (Sub: Pediatric Hematology-Oncology), American Board of Pediatrics
Medical School:
Baylor College of Medicine
University of California, San Francisco Medical Center
University of California, San Francisco Medical Center


Pubmed Profile



Dr. Lam is a tenured Associate Professor of Pediatrics and Biomedical Engineering at Emory and Georgia Institute of Technology, and has a unique background as a physician-scientist-engineer. Dr. Lam obtained his bachelor’s from Rice University, medical doctorate from Baylor College of Medicine and doctorate in bioengineering from the University of California, Berkeley and University of California, San Francisco, where he also completed his clinical training in pediatrics and pediatric hematology/oncology. Dr. Lam’s interdisciplinary laboratory comprises of bioengineers, mechanical engineers, electrical engineers, biologists, chemists and physicians. His laboratory serves as a unique “one-stop shop” in which in vitro microsystems are developed to study the biophysics of hematologic processes in both health and disease, and then translated to the patient bedside. Specifically, Dr. Lam’s lab’s research interests involve the development and application of microsystems to enable research in the biophysical mechanisms of hematologic diseases, such as sickle cell disease, and bleeding and thrombotic disorders, as well as further developing those systems into novel therapeutics and diagnostic devices.

As a bioengineering laboratory with interests in device development, Dr. Lam’s Lab has also developed diagnostic tools for hematologic and pediatric diseases that are inexpensive, simple to operate and can be used in resource-poor settings or as home-based, patient-operated self-tests. A particular interest of Dr. Lam’s is to couple these inexpensive diagnostics with smartphones to enable automated diagnosis and remote data transmission. To those ends, Dr. Lam has co-founded two companies focused on point-of-care diagnostics based on his laboratory’s research and one of their products, a color-based, disposable point-of-care anemia diagnostic was recently awarded U.S. Food and Drug Association clearance for commercialization. Dr. Lam is also the principal investigator of the Atlanta Center for Microsystems Engineering Point-Of-Care Technologies (ACME POCT) Pediatric Device Consortium, which is one of the five funded centers of the Nation Institutes of Health’s (NIH) Point-of-Care Technologies Research Network charged to facilitate the invention, development, clinical translation and commercialization of point-of-care diagnostics. Among other honors, Dr. Lam has been elected into the American Society of Clinical Investigation, named an Emerging Investigator by the journal Lab on a chip published by the Royal Society of Chemistry, and is recipient of a National Science Fair Career Award, as well as the American Society of Pediatric Hematology/Oncology’s Frank A. Oski Memorial Lectureship Award.

Focus of Practice

  • Hematology/oncology
  • Sickle cell disease

Areas of Interest

  • Biomedical engineering


Aflac Cancer and Blood Disorders Center

Egleston Hospital, 1405 Clifton Road NE Atlanta, GA 30322 Get Directions 404-785-1200

Research & Publications

Developing and applying novel technologies using micro/nanotechnology, microfluidics and cell mechanics to research, diagnose, and treat hematologic and oncologic processes

In the News

Lifesaving App Detecs Anemia

Dr. Lam was interviewed by film group Freethink about the development of the smartphone anemia app. The app uses photos of a person’s fingernails with the aim of measuring how much hemoglobin is in their blood.